Raymond James Financial »

Edgewise Therapeutics shares owned by Raymond James Financial

Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by Raymond James Financial from 13F filings

Historical chart of Raymond James Financial investment in Edgewise Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Edgewise Therapeutics held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edgewise Therapeutics by Raymond James Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $217k 13k 16.22
2025-06-30 $20k 1.6k 13.11

More positions owned by Raymond James Financial

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)
Wal-Mart Stores (WMT)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Raymond James Financial

Top funds holding Edgewise Therapeutics

OrbiMed Advisors
RA Capital Management
Baker Bros. Advisors
BlackRock
Paradigm Biocapital Advisors
Novo A/S
Braidwell
Henderson Group
Vanguard Group
Cormorant Asset Management
Siren
Perceptive Advisors
Bellevue Group
Driehaus Capital Management
MPM Oncology Impact Management

View all funds holding Edgewise Therapeutics